Calyxt, Inc. (CLXT) Research
Calyxt, Inc. is a synthetic biology firm that engineers plant-based solutions, primarily serving the agricultural industry in the United States. The company innovates in areas such as developing easily digestible alfalfa, cultivating hemp, and producing wheat varieties with elevated fiber content. They hold an exclusive commercialization pact with S&W Seed Company to license their superior alfalfa seed across both U.S. and international markets. Established in 2010 and headquartered in Roseville, Minnesota, the entity operated as Cellectis Plant Sciences, Inc. before adopting the name Calyxt, Inc. in May 2015. Calyxt, Inc. functions as a subsidiary of Cellectis S.A.
Market snapshot
- Symbol
- CLXT
- Price
- $6.30
- Day change
- +5.53%
- Market cap
- $31.3M
- P/E ratio
- -40.20x
- 52-week range
- 6.01-38.85
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
Peer companies
Recent insider activity
- RIGGS RORY B — C-Conversion (1500000 shares) on 2023-12-29
- RIGGS RORY B — J-Other (1505967 shares) on 2023-12-29
- RIGGS RORY B — J-Other (1505967 shares) on 2023-12-29
- RIGGS RORY B — C-Conversion (1500000 shares) on 2023-12-29
- RIGGS RORY B — C-Conversion (1500000 shares) on 2023-12-29
Open Calyxt, Inc. (CLXT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.